YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ipca Laboratories

Ipca Laboratories

BSE: 524494|NSE: IPCALAB|ISIN: INE571A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 03, 12:46
2040.00
-31.1 (-1.5%)
VOLUME 10,414
LIVE
NSE
Dec 03, 12:47
2041.20
-30.05 (-1.45%)
VOLUME 397,406
News on Ipca Laboratories
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Lyka Labs acquisition by Ipca Laboratories could open strong growth opportunities

1.15 pm | 25 Nov 2021 |  Source: Moneycontrol.com

Near-term growth potential seems to be moderate for Ipca Laboratories but the long-term growth levers are intact and the acquisition of Lyka Labs will...

Buy Ipca Laboratories: target of Rs 2675: Sharekhan

10.41 am | 25 Nov 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2675 in its research report dated November...

Buy Ipca Laboratories: target of Rs 2675: Sharekhan

10.41 am | 25 Nov 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2675 in its research report dated November...

Bulk Deals | Ipca Labs picks 16.73% stake in Lyka Labs, Dolly Khanna buys 0.58% shares in Simran Farms

7.48 pm | 24 Nov 2021 |  Source: Moneycontrol.com

In total, Ipca Labs, so far, bought 76,24,142 equity shares or 26.57 percent stake in Lyka Labs via open market transactions in the current week. Lyka...

IPCA Labs: Domestic beat offsets API weakness

10.38 am | 18 Nov 2021 |  Source: Moneycontrol.com

The key near-term challenge for IPCA is with respect to API sales. The company expects a softer Q3 due to the supply disruption in Sartan APIs and ele...

Buy Ipca Laboratories; target of Rs 2450: Prabhudas Lilladher

1.01 pm | 17 Nov 2021 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2450 in its research report date...

Brokerages see 16% upside in Ipca Labs despite fall in Q2 profit, margin headwinds

11.06 am | 17 Nov 2021 |  Source: Moneycontrol.com

The drug firm reported a 6.30 percent fall in its consolidated net profit to Rs 250.23 crore for the second quarter ended September 30....

Ipca Laboratories Q2 net profit declines 6% to Rs 250 crore

4.27 pm | 13 Nov 2021 |  Source: PTI

The company had posted a net profit of Rs 267.07 crore for the corresponding period of the previous fiscal, Ipca Laboratories said in a regulatory fil...

Ipca Laboratories Q2 PAT seen up 7.3% YoY to Rs 292.6 cr: Prabhudas Lilladher

6.00 pm | 06 Oct 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 10.7 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs 1,437.2 crore, according to Prabhudas Lilladher....

Buy Ipca Laboratories: target of Rs 2850: Sharekhan

2.48 pm | 13 Sep 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2850 in its research report dated Septembe...

Buy Ipca Laboratories; target of Rs 2560: ICICI Direct

11.41 am | 10 Aug 2021 |  Source: Moneycontrol.com

ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2560 in its research report dated Augus...

IPCA Labs: Strong revival for domestic formulations

11.25 am | 09 Aug 2021 |  Source: Moneycontrol.com

IPCA, which was mainly known a few years ago for anti-malarial medications, is now having a significant contribution from non-anti-malarial medicines...

Ipca Labs Consolidated June 2021 Net Sales at Rs 1,565.79 crore, up 2.05% Y-o-Y

6.54 pm | 05 Aug 2021 |  Source: Moneycontrol.com

NULL...

Ipca Labs Standalone June 2021 Net Sales at Rs 1,478.60 crore, down 0.45% Y-o-Y

6.41 pm | 05 Aug 2021 |  Source: Moneycontrol.com

NULL...

Ipca Lab Q1 PAT may dip 53.5% YoY to Rs 207.6 cr: ICICI Direct

7.56 pm | 12 Jul 2021 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 13.9 percent Y-o-Y (up 18.6 percent Q-o-Q) to Rs 1321.4 crore, according to ICICI Direct....

1 2
Quick Links for Ipca Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.